One Novel Self-Expanding Heart Valve

КАРДИОЛОГИЯ УЗБЕКИСТАНА, Journal Year: 2025, Volume and Issue: 18(1), P. 69 - 71

Published: Jan. 1, 2025

Language: Английский

---

Mechanical bionic compression resistant fiber/hydrogel composite artificial heart valve suitable for transcatheter surgery

Composites Part B Engineering, Journal Year: 2025, Volume and Issue: unknown, P. 112234 - 112234

Published: Feb. 1, 2025

Language: Английский

---

Optimal antithrombotic therapy after transcatheter aortic valve replacement: a comprehensive review

Frontiers in Cardiovascular Medicine, Journal Year: 2025, Volume and Issue: 12

Published: March 10, 2025

Transcatheter aortic valve replacement (TAVR) has become a leading treatment for stenosis, but managing thromboembolic and bleeding risks post-procedure remains challenging. This review examines current evidence on antithrombotic therapy after TAVR. Subclinical leaflet thrombosis is observed in 10%–20% of patients, though its clinical significance uncertain. Clinical rare. Current guidelines favor single antiplatelet patients without indications long-term anticoagulation, as dual increases risk improving outcomes. For requiring monotherapy with direct oral anticoagulants or vitamin K antagonists recommended to minimize bleeding. Ongoing trials aim clarify optimal regimens strategies preventing subclinical thrombosis. Individualized based patient profiles likely needed improve the efficacy safety post-TAVR.

Language: Английский

---

Thrombus characterisation and evolution of hypoattenuating leaflet thickening after transcatheter aortic valve implantation

EuroIntervention, Journal Year: 2025, Volume and Issue: 21(9), P. e471 - e481

Published: April 29, 2025

Language: Английский

---

Prosthesis-Patient Mismatch after Aortic Valve Replacement: Valve Size Matters?

Published: Oct. 1, 2024

Language: Английский

---